GetTopicDetailResponse(id=8ed71286151c, topicName=抗HBV新藥, introduction=, content=慢性乙型肝炎 抗HBV新藥, image=null, comments=0, allHits=123, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Jul 16 09:11:44 CST 2025, time=2025-07-16, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=506517, tagList=[TagDto(tagId=506517, tagName=抗HBV新藥)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2273566, encodeId=7a9322e3566b8, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a> <a href='/topic/show?id=8ed71286151c' target=_blank style='color:#2F92EE;'>#抗HBV新藥#</a>, objectTitle=【期刊導(dǎo)讀】系統(tǒng)評價與薈萃分析：乙肝新藥總體臨床治愈率為0%，療效有限, objectType=article, longId=878339, objectId=b0078e8339e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720157205619_5579292.jpg, objectUrl=/article/show_article.do?id=b0078e8339e0, replyNumber=0, likeNumber=39, createdTime=2025-07-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b0078e8339e0, moduleTitle=【期刊導(dǎo)讀】系統(tǒng)評價與薈萃分析：乙肝新藥總體臨床治愈率為0%，療效有限, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b0078e8339e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-07-16發(fā)表于上海
